Md. Code Regs. 30.08.12.12
III | IV | |
A hospital shall have: | ||
A. Emergency medications, as listed in the current Neonatal Resuscitation Program (NRP) guidelines, shall be immediately available in the delivery area and neonatal units; | E | E |
B. The following medications shall be immediately available to the neonatal units: | ||
(1) Antibiotics, anticonvulsants, and emergency cardiovascular drugs; and | ||
(2) Surfactant, prostaglandin E1; | E | E |
C. All emergency resuscitation medications to initiate and maintain resuscitation, in accordance with current Advanced Cardiac Life Support (ACLS) guidelines of the American Heart Association (AHA), shall be immediately available in the delivery area; | E | E |
D. The following medications shall be immediately available for management of obstetrical hemorrhage in the delivery area and postpartum floor: (1) Oxytocin (Pitocin); (2) Methylergonovine (Methergine); (3) Misoprostol (Cytotec); (4) Carboprost tromethamine (Hemabate); and (5) Tranezamic acid (TXA); and | E | E |
E. The following medications shall be immediately available for management of hypertensive crisis in all obstetrical care areas: (1) Hydralazine; (2) Labetalol; and (3) Nifedipine. | E | E |
Md. Code Regs. 30.08.12.12
Regulation .12 amended effective 42:6 Md. R. 514, eff.3/30/2015; amended effective 49:20 Md. R. 913, eff. 10/3/2022